Chugai Pharmaceuticals is Japan's leading pharmaceutical company, providing innovative treatments and medicines to improve the health and well-being of people around the world. With a long history of success and innovation, Chugai is committed to providing the highest quality products and services to
From Wikipedia
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.